Announcing the NeuroMatch Ambassador Program. Be among the first to join our closed beta.

Transforming Neurological Healthcare

At LVIS Corporation, we are dedicated to enhancing neurological healthcare through cutting-edge technology. Our team is driven by a passion for innovation and a commitment to solving complex neurological challenges. Together, we can expand the delivery of neurological care to those in need, while we redefine the landscape of neurological diagnosis and treatment, one breakthrough at a time, with our advanced neural information analysis tools.

LVIS: AT A GLANCE

THE LVIS STORY

Commitment to Innovation

Established in 2013 and based in Palo Alto, California, LVIS Corporation is a pioneer in the field of neurotechnology. With exclusive licenses of patents from esteemed institutions like UCLA and Stanford, plus our own robust IP, we provide unparalleled tools to empower physicians. Our commitment to innovation is bolstered by over a decade of research led by our founder, Jin Hyung Lee, an Associate Professor of Neurology, Neurosurgery, and Bioengineering at Stanford University.

We’re Hiring

Explore our open roles and discover how you can make a difference in the lives of those in need of advanced neurological care by working at our company.

Latest News
Press Releases
Announcing the NeuroMatch Ambassador Program: Your Expertise, Our Innovation
NeuroMatch software user
Press Releases
LVIS Corporation Introduces NeuroMatch® at 2024 American Clinical Neurophysiology Society Meeting
ACNS Orlando feature image
Press Releases
LVIS Corporation to Showcase Innovative Epilepsy Solution at the 2023 American Epilepsy Society Meeting
AES Orlando feature image
LVIS Timeline

History in the Making

2013

  • Established LVIS Corporation in Palo Alto, California USA

2014

  • Exclusive license established with UCLA

2015

  • Exclusive license established with Stanford University

2018

  • Established Seoul Office

2022

  • Expanded to new LVIS World Headquarters building in Palo Alto, CA

2023

  • First FDA clearance for NeuroMatch in the USA
  • First MFDS clearance for NeuroMatch in South Korea
  • Established Daegu Office
  • First exhibit at AES

2024

  • First exhibit at ACNS
  • We will have much to share here very soon!